84
Participants
Start Date
September 30, 2010
Primary Completion Date
December 11, 2018
Study Completion Date
December 11, 2028
Tamoxifen Citrate
5 mg PO Daily
Placebo
1 tablet daily
Digital mammography
Correlative studies
immunohistochemistry staining method
Correlative Studies
pharmacological study
Correlative Studies
laboratory biomarker analysis
Correlative Studies
protein expression analysis
correlative studies
pharmacogenomic studies
correlative studies
questionnaire administration
Ancillary studies
Fine needle aspiration
Quality of Life Assessment
Ancillary Studies
Wake Forest University, Winston-Salem
University of Alabama at Birmingham, Birmingham
St. Jude Children's Research Hospital, Memphis
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
University of Chicago, Chicago
MD Anderson, Houston
University of Colorado, Anschutz Medical Campus, Aurora
City of Hope Medical Center, Duarte
Seattle Cancer Care Alliance, Seattle
Dana-Farber Cancer Institute, Boston
University of Michigan, Ann Arbor
University Health Network, Toronto, Toronto
Collaborators (1)
National Cancer Institute (NCI)
NIH
St. Jude Children's Research Hospital
OTHER
University Health Network, Toronto
OTHER
University of Michigan
OTHER
Dana-Farber Cancer Institute
OTHER
Mayo Clinic
OTHER
University of Washington
OTHER
City of Hope National Medical Center
OTHER
M.D. Anderson Cancer Center
OTHER
University of Chicago
OTHER
University of Minnesota
OTHER
University of Colorado, Denver
OTHER
Wake Forest University
OTHER
University of Alabama at Birmingham
OTHER